top of page

enter here
Ketamine and Prolonged Exposure in PTSD
About the study
NCT Trial Number
NCT03960658
The drug being studied
Ketamine


Sponsored by
Minneapolis Veterans Affairs Medical Center

Trial Start Date
Apr-18

About the participants
Age seeking
18 Years to 75 Years
gender
All

Primary condition of volunteers accepted
PTSD

Accepts healthy volunteers?
No
This study aims at investigating the effectiveness of the drug, Ketamine, in combination with Prolonged Exposure (PE) therapy for people suffering from PTSD.

Locations
United States, Minnesota
Minneapolis VA Medical Center
Minneapolis, Minnesota, United States, 55417
Contact: Eric Baltutis, BA
612-467-2974
eric.baltutis@va.gov
bottom of page